USP48 and hepatocellular carcinoma: Similarly, USP48, primarily localized to the nucleus, impedes metabolic reprogramming to inhibit hepatocellular carcinoma development by removing K48-linked ubiquitination at the K33 and K128 sites of SIRT6 to stabilize SIRT6 [23].